Home Tags Everest Medicines Limited

Tag: Everest Medicines Limited

Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Medical

Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint

Marie Jones -
0
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis
Medical

Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis

Marie Jones -
0
Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM
Medical

Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM

Marie Jones -
0
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Medical

Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis

Marie Jones -
0
Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013
Medical

Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013

Marie Jones -
0
Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares
Medical

Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares

Marie Jones -
0
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Medical

Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten

Marie Jones -
0
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
Medical

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders

Marie Jones -
0
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
Medical

Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14

Marie Jones -
0
Everest Medicines Announces 2025 Interim Results: ‘Dual-Engine’ Strategy Driving Strong Synergies Between Commercialization and R&D
Medical

Everest Medicines Announces 2025 Interim Results: ‘Dual-Engine’ Strategy Driving Strong Synergies Between Commercialization and R&D

Marie Jones -
0
12Page 1 of 2